Cannovum Cannabis AG Logo

Cannovum Cannabis AG

Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.

27N0 | DU

Overview

Corporate Details

ISIN(s):
DE000A30VHF2 (+2 more)
LEI:
894500IT61F9P85YMM31
Country:
Germany
Address:
Stresemannstraße 23, 10963 Berlin
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cannovum Cannabis AG is a pharmaceutical company that operates as an importer, wholesaler, and manufacturer of medical cannabis products. The company focuses on providing patients with cannabis-based therapies, supported by medical-scientific education and distribution services. As one of the first fully licensed cannabis companies to be publicly listed in Germany, Cannovum is leveraging its market position to expand into the emerging recreational cannabis sector. This strategic expansion includes providing cultivation areas and infrastructure for cannabis social clubs to address the adult-use consumer market following recent legalization.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-02-27 21:05
Delisting Announcement
Cannovum Cannabis AG: Liquidation and sale of investments in the cannabis sector
English 5.8 KB
2025-02-26 21:05
Delisting Announcement
Cannovum Cannabis AG: Liquidation and sale of investments in the cannabis sector
English 5.8 KB
2024-08-01 07:36
Regulatory News Service
Cannovum Cannabis AG: Far-reaching partnership with H.i. Greeny+ GmbH and H.i C…
English 9.4 KB
2024-06-26 09:34
Regulatory News Service
Cannovum Cannabis AG: 'Cannabis for Germany', sale of fake hemp in 1,000 Aldi S…
English 9.0 KB
2024-06-07 07:00
Legal Proceedings Report
Cannovum Cannabis AG: Bundestag confirms Cannovum Cannabis AG's business model …
English 7.6 KB
2024-06-04 10:20
Share Issue/Capital Change
Cannovum Cannabis AG: Cash capital increase from authorized capital with subscr…
English 5.9 KB
2024-03-22 11:45
Regulatory News Service
Cannovum Cannabis AG: Federal Council confirms cannabis legalization as of Apri…
English 9.5 KB
2024-03-05 09:30
Regulatory News Service
Cannovum Cannabis AG: Areas for more than 500 cannabis clubs are available in t…
English 9.0 KB
2024-03-05 06:59
Regulatory News Service
Cannovum Cannabis AG: Areas for more than 500 cannabis clubs are available in t…
English 9.1 KB
2024-02-23 15:51
Regulatory News Service
Cannovum Cannabis AG: Bundestag approves legalization of cannabis in Germany, h…
English 8.1 KB
2024-02-02 09:37
Earnings Release
Cannovum Cannabis AG: April 2024 starts the legalization of cannabis in Germany…
English 7.8 KB
2023-11-14 15:55
Board/Management Information
Cannovum Cannabis AG: High-profile business leaders from advertising and retail…
English 7.3 KB
2023-11-06 13:39
Regulatory News Service
Cannovum Cannabis AG: Legalization of cannabis is imminent, new premium partner…
English 10.6 KB
2023-08-07 07:30
Regulatory News Service
Cannovum Cannabis AG: Exclusive partnership and million-dollar sales potential …
English 9.2 KB
2023-07-17 10:47
Regulatory News Service
Cannovum Cannabis AG: New partner strengthens offer for private cultivation of …
English 10.4 KB

Automate Your Workflow. Get a real-time feed of all Cannovum Cannabis AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Cannovum Cannabis AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
KOA SHOJI HOLDINGS CO.,LTD. Logo
Imports APIs and manufactures generic drugs for Japan's pharmaceutical industry.
Japan 9273
KOBAYASHI PHARMACEUTICAL  CO.,LTD. Logo
Manufactures OTC pharma, personal care, and household goods for niche consumer markets.
Japan 4967
Kohjin Bio Co., Ltd. Logo
A CDMO providing culture media & bioservices for cell therapy, research, and diagnostics.
Japan 177A
KOLON LIFE SCIENCE Inc. Logo
Develops gene therapies and manufactures APIs, providing global CDMO/CMO services.
South Korea 102940
Kolon TissueGene, Inc. Logo
Developing cell and gene therapies for orthopedic and degenerative disorders.
United States of America 950160
Develops animal health products and novel drugs for human cancer and autoimmune diseases.
South Korea 041960
KOREA ARLICO PHARM CO.,LTD. Logo
Manufactures generic drugs and provides CDMO services to a global market.
South Korea 260660
Develops and manufactures prescription (ETC) and over-the-counter (OTC) medicines for public health.
South Korea 014570
K Pharma,Inc. Logo
Develops iPS cell-based drugs and regenerative medicine for central nervous system disorders.
Japan 4896
Kringle Pharma,Inc. Logo
Develops regenerative HGF medicines for rare and intractable neurological diseases.
Japan 4884

Talk to a Data Expert

Have a question? We'll get back to you promptly.